- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Dynacin, Minocin, Minocin Kit, Minolira, Solodyn, Ximino
Synonyms :
minocycline
Class :
Tetracyclines
Dosage Forms & Strengths
Tablet or Capsule
50mg
75mg
100mg
Tablet- extended release
45mg
55mg
65mg
80mg
90mg
105mg
135mg
initial dose:
200
mg
Intravenous (IV)
followed by 100 mg IV for every 12hrs maximum dose: 400 mg IV per day
for 45-49 kg weight 45 mg orally once a day
for 50-59 kg weight 55 mg orally once a day
for 60-71 kg weight 65 mg orally once a day
for 72-84 kg weight 80 mg orally once a day
for 85-96 kg weight 90 mg orally once a day
for 97-110 kg weight 105 mg orally once a day
for 111-125 kg weight 115 mg orally once a day
for 126-136 kg weight 135 mg orally once a day
maximum duration of the treatment is 12 weeks
200 mg IV given initially, followed by 100 mg IV every 12hrs
maximum dose given per day is 400 mg
Meningococcal Meningitis Prophylaxis:
100 mg given orally every 12hrs for about five days
200 mg IV given initially, followed by 100 mg IV every 12hrs
maximum dose given per day is 400 mg
200 mg given initially, followed by 100 mg orally every 12hrs
100 to 200 mg initially followed by 50 mg orally four times a day for an alternative regimen
100 mg orally every 12hrs for five days for urethritis in men
200 mg initially followed by 100 mg orally every 12hrs for at least four days for infections other than urethritis and anorectal infections in men
Dosage Forms & Strengths
Tablet or capsule
50mg
75mg
100mg
Tablet-extended release
45mg
55mg
65mg
80mg
90mg
105mg
135mg
Age: >12years
Extended-release formulations:
for 45-49 kg weight 45 mg orally once a day
for 50-59 kg weight 55 mg orally once a day
for 60-71 kg weight 65 mg orally once a day
for 72-84 kg weight 80 mg orally once a day
for 85-96 kg weight 90 mg orally once a day
for 97-110 kg weight 105 mg orally once a day
for 111-125 kg weight 115 mg orally once a day
for 126-136 kg weight 135 mg orally once a day
maximum duration of treatment is 12 weeks
For > 8 years:
4 mg per kg given orally or IV initially followed by 2 mg per kg orally or IV every 12hrs
Maximum dose 200 mg per dose initially followed by 200 mg per day
When both drugs are combined, there may be an increased intracranial pressure
When both drugs are combined, there may be an increased intracranial pressure
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
aluminum hydroxide/magnesium carbonate
may decrease the serum concentration of antacids
When both drugs are combined, there may be a decrease in levels of minocycline by inhibition of GI absorption
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be a decreased therapeutic effect of the vaccine
when both drugs are combined, there may be a decrease in levels of minocycline by inhibition of GI absorption
When both drugs are combined, there may be a decrease in levels of the other by inhibition of GI absorption
When both drugs are combined, there may be a decrease in levels of the other by inhibition of GI absorption
When both drugs are combined, there may be a decrease in levels of the other by inhibition of GI absorption
When both drugs are combined, there may be a decrease in levels of the other by inhibition of GI absorption
bismuth subsalicylate reduces the levels of minocycline by inhibiting gastrointestinal absorption
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with minocycline it decreases the effects of action of drug by antagonism effect
amoxicillin and clavulanate potassium
when amoxicillin combines with minocycline it decreases the effects of action of drug by antagonism effect
omeprazole amoxicillin and clarithromycin
when both drugs are combined, there may be a decreased effect of the drug's action by antagonism effect
when both drugs are combined, there may be a decreased effect of the drug's action by antagonism effect
may diminish the absorption of magnesium salts
aluminum hydroxide/magnesium hydroxide
may diminish the absorption of Antacids
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be an increased risk or severity of adverse effects
When both drugs are combined, there may be a decreased effect of conjugated estrogens by altering intestinal flora
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
